Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
10.1016/j.jacc.2024.08.004 21
Brand-name medications like Mounjaro and Zepbound are FDA-approved
10.1093/ntr/ntab066 Summary Keywords obesity, barriers, GLP-1 agonists, nicotine, antidepressant use Citation Alhowiti A, Mirghani H, Abdulrahman Qrmli A, Albalawi AA and Abdulrahman Aljohani R (2025) Barriers to glucagon-like peptide-1 agonists used for obesity management among the general population in Tabuk City, Saudi Arabia, and their relation to smoking cessation and antidepressants
Should You Stop Taking GLP-1 Injections Because of Hair Loss
Product ID:15900364
The data generated during this phase help define the dose range that may be explored in subsequent studies and contribute to understanding exposure-response relationships, pharmacokinetic behavior and safety considerations associated with the investigational compound
US$ 25.21
US$ 22.24
US$ 26.08
US$ 23.34
US$ 29.51
US$ 27.12
US$ 22.87
